AN-721

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAN-721
Drug Alias NameNSD-721AN-721
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor alpha-3 modulatorsGamma-aminobutyric acid A receptor alpha-2 modulators
TargetsGamma-aminobutyric acid A receptor alpha-2Gamma-aminobutyric acid A receptor alpha-3
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeurosearch As
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A